Biosynthesis of Eumelanin in Melanoma and Biochemical Markers of Melanoma

黑色素瘤中真黑素的生物合成及黑色素瘤的生化标志物

基本信息

  • 批准号:
    63570484
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

1. Simplified method for preparing enmelanin-related metabolites Dopachrome solution, firepared by chemical oxidation of dopa, was kept under different pH to yield 5,6DHI and 5,6DHI2C. Treatment with diazomethane afforded their O-methyl derivatives. This enabled us to obtain standard compounds necessary for the following research.2. Importance of enmelanin-related metabolites as biochemical markers of melanoma (1) Excretion of melanin-related metabolites was examined in mice bearing B16 melanoma. In early stage of tumor progression, the increase of 5H6MI2C was found to be more pronounced than of 5-S-CD, a commonly used marker. (2) Correlation among the contents of melanin-related metabolites in tumor, serum, and urine was examined in mice bearing B16 melanoma. Good correlation was found between serum indoles (5H6MI2C + 6H5MI2C) or 5-S-CD and tumor weight (r = 0.92, 0.89, respectively). Urinary metabolites did not show a significant correlation. These results suggest that melanin-related metabolites in serum may better reflect progression of melanoma than those in urine. (3) High levels of glucronide and sulfate conjugates of indoles were found in urine of a melanoma patient. Only sulfate conjugates were detected in urine of melanoma-bearing mice.Serum and urine samples from healthy subjects and melanoma patients will be analyzed for indoles and 5-S-CD to compare their usefulness in early diagnosis and prognosis of melanoma.
1. 采用多巴化学氧化法制备的Dopachrome溶液,在不同的pH条件下,得到5,6dhi和5,6dh2c。用重氮甲烷处理得到它们的邻甲基衍生物。这使我们能够得到下列研究所必需的标准化合物。黑色素相关代谢物作为黑色素瘤生化标志物的重要性(1)在B16黑色素瘤小鼠中检测了黑色素相关代谢物的排泄。在肿瘤进展的早期,5H6MI2C的升高比5-S-CD(一种常用的标志物)更为明显。(2)检测B16黑色素瘤小鼠肿瘤、血清和尿液中黑色素相关代谢物含量的相关性。血清吲哚(5H6MI2C + 6H5MI2C)或5-S-CD与肿瘤重量有较好的相关性(r分别为0.92、0.89)。尿代谢物无显著相关性。这些结果表明血清中的黑色素相关代谢物可能比尿液中的代谢物更好地反映黑色素瘤的进展。(3)在黑色素瘤患者的尿液中发现了高水平的葡萄糖醛酸和吲哚硫酸盐缀合物。在黑色素瘤小鼠尿液中只检测到硫酸盐缀合物。将对健康受试者和黑色素瘤患者的血清和尿液样本进行吲哚和5-S-CD分析,比较它们在黑色素瘤早期诊断和预后中的作用。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shosuke Ito,Kazumasa Wakamatsu,Shigeki Inoue,Keisuke Fujita: "Correlation between Urinary Melanin-related Metabolites and Tumour Weight in Melanoma-bearing Mice" Acta Dermato-Venereologica(Stockholm). 69. 380-384 (1989)
Shosuke Ito、Kazumasa Wakamatsu、Shigeki Inoue、Keisuke Fujita:“黑色素瘤小鼠尿液黑色素相关代谢物与肿瘤重量的相关性”Acta Dermato-Venereologica(斯德哥尔摩)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kazumasa Wakamatsu: "Identification of Ester Glucronide and Sulfate Conjugates of 5-Hydroxy-6-methoxyindole-2-carboxylic Acid and 6-Hydroxy-5-methoxyindole-2-carboxylic Acid in Melanoma Urine" Journal of Dermatological Research.
Kazumasa Wakamatsu:“黑色素瘤尿液中 5-羟基-6-甲氧基吲哚-2-羧酸和 6-羟基-5-甲氧基吲哚-2-羧酸的酯葡萄糖苷和硫酸盐缀合物的鉴定”皮肤病学研究杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shosuke Ito,Kazumasa Wakamatsu: "Melanin Chemistry and Melanin Precursors in Melanoma" Journal of Investigative Dermatology. 89. 261S-265S (1989)
Shosuke Ito、Kazumasa Wakamatsu:“黑色素化学和黑色素瘤中的黑色素前体”皮肤病学研究杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kazumasa Wakamatsu: "Preparation of Eumelanin-related Metabolites 5, 6-Dihydroxyindole, 5, 6-Dihydroxyindole-2-carboxylic Acid, and Their 0-Methyl Derivatives" Analytical Biochemistry 170: 335-340, 1988.
Kazumasa Wakamatsu:“真黑素相关代谢物 5, 6-二羟基吲哚、5, 6-二羟基吲哚-2-羧酸及其 0-甲基衍生物的制备”,《分析生物化学》170:335-340,1988。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shosuke Ito,;Kazumasa Wakamatsu.: Journal of Investigative Dermatology. 89. (1989)
Shosuke Ito,;Kazumasa Wakamatsu。:皮肤病学研究杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITO Shosuke其他文献

ITO Shosuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITO Shosuke', 18)}}的其他基金

Elucidation of ultraviolet radiation-induced physiological degradation pathway of eumelanin and pheomelanin and its physiological significance
紫外辐射诱导的真黑素和褐黑素生理降解途径及其生理意义的阐明
  • 批准号:
    26461705
  • 财政年份:
    2014
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of ultraviolet radiation-induced physiological degradation pathway of eumelanin and pheomelanin
阐明紫外线辐射诱导的真黑素和褐黑素的生理降解途径
  • 批准号:
    23591659
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control mechanism of melanogenesis by pigmentation-related genes and ultraviolet radiation
色素沉着相关基因和紫外线对黑色素生成的控制机制
  • 批准号:
    20591357
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of regulation of melanin synthesis by coat color genes and ultraviolet radiation in mice and human
毛色基因和紫外线调节小鼠和人类黑色素合成的机制
  • 批准号:
    18591262
  • 财政年份:
    2006
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation mechanism of melanin production by related-genes and UV.
相关基因和紫外线对黑色素生成的调控机制。
  • 批准号:
    14570829
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic and non-genetic regulation mechanism of melanin production in the mammal
哺乳动物黑色素产生的遗传和非遗传调控机制
  • 批准号:
    12670844
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANALYSIS OF REGULATIVE FUNCTION OF MELANIN-RELATED GENE EXPRESSION BY BIOCHEMICALAND CELLULAR BIOLOGICAL METHODS
生物化学和细胞生物学方法分析黑色素相关基因表达的调控功能
  • 批准号:
    10670812
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functions of Melanogenesis-Related Genes by Chemical and Biochemical Methods
通过化学和生化方法研究黑素生成相关基因的功能
  • 批准号:
    07670971
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biochemical Markers of Melanoma Utilizing Melanin Formation
利用黑色素形成的黑色素瘤的生化标志物
  • 批准号:
    02670487
  • 财政年份:
    1990
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development of a novel therapeutic drug targeting both MDM4 and PKC, critical points in uveal malignant melanoma
开发针对葡萄膜恶性黑色素瘤关键点 MDM4 和 PKC 的新型治疗药物
  • 批准号:
    23K09020
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel treatment targeting the immunosuppressive mechanism of MDSC for canine malignant melanoma
针对MDSC免疫抑制机制开发犬恶性黑色素瘤新疗法
  • 批准号:
    23K05561
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A new treatment for malignant melanoma based on the concept of compartmentalization of cAMP-PDE2 signal transduction
基于cAMP-PDE2信号转导区室化概念的恶性黑色素瘤新疗法
  • 批准号:
    22K10144
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of cancer progression induced by TGF-beta to develop novel therapies for canine malignant melanoma
阐明TGF-β诱导癌症进展的机制,开发犬恶性黑色素瘤的新疗法
  • 批准号:
    21K14973
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the effect of ALDH2 gene polymorphism on the onset and prognosis of malignant melanoma
阐明ALDH2基因多态性对恶性黑色素瘤发病及预后的影响
  • 批准号:
    21K16218
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
new therapeutic target molecules for malignant melanoma focusing on epigenomic information
关注表观基因组信息的恶性黑色素瘤新治疗靶分子
  • 批准号:
    21K16221
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
the role of HMGB1 in autophagy of malignant melanoma
HMGB1在恶性黑色素瘤自噬中的作用
  • 批准号:
    20K18438
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Biomarkers for predicting response to immune checkpoint inhibitor therapy in malignant melanoma.
用于预测恶性黑色素瘤免疫检查点抑制剂治疗反应的生物标志物。
  • 批准号:
    20K07449
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of cytoskeletal regulator Plectin in growth, invasion, and metastasis of malignant melanoma.
细胞骨架调节因子 Plectin 在恶性黑色素瘤生长、侵袭和转移中的作用。
  • 批准号:
    20K10185
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical role of EPCR expression in malignant melanoma
EPCR表达在恶性黑色素瘤中的临床作用
  • 批准号:
    20K17330
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了